Source: Business Wire
Epiq Animal Health and Interpath Global have partnered to bring 4CYTE™, a groundbreaking joint health nutraceutical, to the U.S. animal health market. Previously available only internationally, 4CYTE™ features Epiitalis®, a patented, plant-derived ingredient scientifically proven to improve joint health in dogs and horses. This natural and sustainable supplement is highly digestible and has undergone extensive safety and efficacy testing since 2008, with results published in leading international journals.
Rebecca Britton, General Manager, highlights the product’s exceptional clinical outcomes and global success. The partnership aims to streamline supply chain solutions and provide education and training for U.S. Veterinary professionals. Available through Covetrus and soon other distributors, 4CYTE™ distinguishes itself in the crowded joint health market with its unique ingredients, disease-modifying properties, and proven results. Epiq Animal Health’s mission to deliver innovative products aligns with this launch, offering veterinarians and pet owners access to cutting-edge solutions for joint health.
Read the full story HERE: https://www.businesswire.com/news/home/20241216218459/en/epiq-Animal-Health-and-Interpath-Global-Announce-Partnership-to-Enhance-the-Joint-Health-Product-Offering-for-Distributors-and-Veterinarians